Back

Vocal biomarker predicts long term survival among heart failure patients

27 August 2018 (17:15 - 17:30)
Organised by:
Congress Presentation Part of: The potential of new and unusual biomarkers in heart failure Biomarkers ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Elad Maor

Sheba Medical Center, Tel Aviv (Israel)

3 More presentations in this session

Presentation thumbnail
Carpal tunnel syndrome is associated with an increased risk of heart failure carrying a poor prognosis
Doctor E. Fosbol (Copenhagen, DK)
Abstract
Presentation thumbnail
Circulating miRNAs as a prognostic tool for heart failure related morbidity and mortality in patients suffering from stable HFpEF: a subgroup analysis of the ALDO-DHF trial
Mr J. Petutschnigg (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Prognostic implications of pathogenic truncating variants in the TTN gene
Doctor M. Cicerchia (Espoo, FI)
Abstract Slides Video

Access the full session

Session thumbnail
The potential of new and unusual biomarkers in heart failure

The Event

Event poster

ESC Congress 2018

27 August 2018 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Voice-based remote monitoring for the early detection of adverse events in chronic heart failure: rationale and design of the TIM-HF3 voice substudy
22 November 2025
thumbnail
Congress Presentation
Comparison of four novel biomarkers alongside NT-proBNP for risk assessment of heart failure or death within 1 year from admission with acute dyspnoea
1 September 2025
thumbnail
Congress Presentation
Inflammation in endomyocardial biopsies correlates with improved cardiac recovery and correlates inversely with mortality in patients with non-ischemic heart failure with reduced ejection fraction
26 August 2023
thumbnail
Congress Presentation
Prognostic value of the new personalized scoring system in heart failure patients
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources